Kevin Chartier

Kevin Chartier serves as the Principal Advisor for Biostatistics and Submission Planning at MMS since November 2021, facilitating support for Sponsors on complex studies and submissions across various therapeutic areas, including rare diseases. Previously, Kevin held the position of Vice President of Biostatistics and Statistical Programming at Astellas Pharma from May 2014 to November 2021, where leadership was provided in statistical design and drug development across global markets. Prior roles include Executive Director of Global Biostatistics at Novartis and Vice President of Biometrics at United BioSource Corporation, showcasing extensive operational and strategic expertise in biostatistics. Kevin's career began at MDS Pharma Services as a Senior Biostatistician, culminating in a PhD in Statistics from Kansas State University.